BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 14746860)

  • 41. Neoadjuvant chemotherapy before surgery of hepatoblastoma.
    Udupa KV; Navadgi SM; Mullerpatan P; Chhabra D; Shah RC; Jagannath P
    Indian J Pediatr; 2006 Aug; 73(8):735-7. PubMed ID: 16936371
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment outcome and pattern of failure in hepatoblastoma treated with a consensus protocol in Hong Kong.
    Liu APY; Ip JJK; Leung AWK; Luk CW; Li CH; Ho KKH; Lo R; Chan EKW; Chan ACY; Chung PHY; Chiang AKS
    Pediatr Blood Cancer; 2019 Jan; 66(1):e27482. PubMed ID: 30270490
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: A report from the Children's Cancer Group and the Pediatric Oncology Group.
    Ortega JA; Douglass EC; Feusner JH; Reynolds M; Quinn JJ; Finegold MJ; Haas JE; King DR; Liu-Mares W; Sensel MG; Krailo MD
    J Clin Oncol; 2000 Jul; 18(14):2665-75. PubMed ID: 10894865
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Guidelines for surgical treatment of hepatoblastoma in the modern era--recommendations from the Childhood Liver Tumour Strategy Group of the International Society of Paediatric Oncology (SIOPEL).
    Czauderna P; Otte JB; Aronson DC; Gauthier F; Mackinlay G; Roebuck D; Plaschkes J; Perilongo G;
    Eur J Cancer; 2005 May; 41(7):1031-6. PubMed ID: 15862752
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
    van As JW; van den Berg H; van Dalen EC
    Cochrane Database Syst Rev; 2012 May; (5):CD009219. PubMed ID: 22592737
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pretreatment prognostic factors for children with hepatoblastoma-- results from the International Society of Paediatric Oncology (SIOP) study SIOPEL 1.
    Brown J; Perilongo G; Shafford E; Keeling J; Pritchard J; Brock P; Dicks-Mireaux C; Phillips A; Vos A; Plaschkes J
    Eur J Cancer; 2000 Jul; 36(11):1418-25. PubMed ID: 10899656
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Unresectable multifocal hepatoblastoma with cardiac extension: excellent response with HB-94 chemotherapy protocol.
    Sarper N; Corapçioğlu F; Anik Y; Ural D; Yildiz K; Tugay M
    J Pediatr Hematol Oncol; 2006 Jun; 28(6):386-90. PubMed ID: 16794509
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development of a drug resistance model for hepatoblastoma.
    Eicher C; Dewerth A; Kirchner B; Warmann SW; Fuchs J; Armeanu-Ebinger S
    Int J Oncol; 2011 Feb; 38(2):447-54. PubMed ID: 21132272
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Upfront window vincristine/irinotecan treatment of high-risk hepatoblastoma: A report from the Children's Oncology Group AHEP0731 study committee.
    Katzenstein HM; Furman WL; Malogolowkin MH; Krailo MD; McCarville MB; Towbin AJ; Tiao GM; Finegold MJ; Ranganathan S; Dunn SP; Langham MR; McGahren ED; Rodriguez-Galindo C; Meyers RL
    Cancer; 2017 Jun; 123(12):2360-2367. PubMed ID: 28211941
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HGF/c-Met related activation of β-catenin in hepatoblastoma.
    Purcell R; Childs M; Maibach R; Miles C; Turner C; Zimmermann A; Sullivan M
    J Exp Clin Cancer Res; 2011 Oct; 30(1):96. PubMed ID: 21992464
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatoblastoma: an oncological review.
    Roebuck DJ; Perilongo G
    Pediatr Radiol; 2006 Mar; 36(3):183-6. PubMed ID: 16404556
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Outcome of hepatoblastomas treated using the Japanese Study Group for Pediatric Liver Tumor (JPLT) protocol-2: report from the JPLT.
    Hishiki T; Matsunaga T; Sasaki F; Yano M; Ida K; Horie H; Kondo S; Watanabe K; Oue T; Tajiri T; Kamimatsuse A; Ohnuma N; Hiyama E
    Pediatr Surg Int; 2011 Jan; 27(1):1-8. PubMed ID: 20922397
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Staged resection for a ruptured hepatoblastoma: a 6-year follow-up.
    Madanur MA; Battula N; Davenport M; Dhawan A; Rela M
    Pediatr Surg Int; 2007 Jun; 23(6):609-11. PubMed ID: 17066271
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relapses in hepatoblastoma patients: clinical characteristics and outcome--experience of the International Childhood Liver Tumour Strategy Group (SIOPEL).
    Semeraro M; Branchereau S; Maibach R; Zsiros J; Casanova M; Brock P; Domerg C; Aronson DC; Zimmermann A; Laithier V; Childs M; Roebuck D; Perilongo G; Czauderna P; Brugieres L
    Eur J Cancer; 2013 Mar; 49(4):915-22. PubMed ID: 23146961
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Liver transplantation for hepatoblastoma.
    Faraj W; Dar F; Marangoni G; Bartlett A; Melendez HV; Hadzic D; Dhawan A; Mieli-Vergani G; Rela M; Heaton N
    Liver Transpl; 2008 Nov; 14(11):1614-9. PubMed ID: 18975296
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Improved survival outcome for hepatoblastoma based on an optimal chemotherapeutic regimen--a report from the study group for pediatric solid malignant tumors in the Kyushu area.
    Suita S; Tajiri T; Takamatsu H; Mizote H; Nagasaki A; Inomata Y; Hara T; Okamura J; Miyazaki S; Kawakami K; Eguchi H; Tsuneyoshi M;
    J Pediatr Surg; 2004 Feb; 39(2):195-8; discussion 195-8. PubMed ID: 14966739
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of postoperative complications on overall survival of patients with hepatoblastoma.
    Becker K; Furch C; Schmid I; von Schweinitz D; Häberle B
    Pediatr Blood Cancer; 2015 Jan; 62(1):24-8. PubMed ID: 25251521
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy of irinotecan single drug treatment in children with refractory or recurrent hepatoblastoma--a phase II trial of the childhood liver tumour strategy group (SIOPEL).
    Zsíros J; Brugières L; Brock P; Roebuck D; Maibach R; Child M; Morland B; Casanova M; Pariente D; Paris C; de Camargo B; Ronghe M; Zimmermann A; Plaschkes J; Czauderna P; Perilongo G
    Eur J Cancer; 2012 Dec; 48(18):3456-64. PubMed ID: 22835780
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chemotherapeutic approaches for newly diagnosed hepatoblastoma: past, present, and future strategies.
    Trobaugh-Lotrario AD; Katzenstein HM
    Pediatr Blood Cancer; 2012 Nov; 59(5):809-12. PubMed ID: 22648979
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of infantile hepatoblastoma and related complications.
    Ueno S; Hirakawa H; Yokoyama S; Hinoki T; Tobita K; Ohtani Y; Imaizumi T; Makuuchi H; Iwata Y; Imai Y
    Tokai J Exp Clin Med; 2005 Dec; 30(4):203-9. PubMed ID: 16482940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.